ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 55 filers reported holding ADMA BIOLOGICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,400,000 | -2.0% | 600,000 | +9.1% | 1.63% | -13.3% |
| Q3 2019 | $2,448,000 | +15.0% | 550,000 | 0.0% | 1.88% | +28.2% |
| Q2 2019 | $2,129,000 | -2.3% | 550,000 | -4.3% | 1.47% | -6.0% |
| Q1 2019 | $2,179,000 | +127.9% | 575,000 | +43.8% | 1.56% | +83.4% |
| Q4 2018 | $956,000 | -59.0% | 400,000 | +6.7% | 0.85% | -44.2% |
| Q3 2018 | $2,329,000 | +37.7% | 375,000 | 0.0% | 1.52% | +27.1% |
| Q2 2018 | $1,691,000 | +22.5% | 375,000 | +25.0% | 1.20% | +14.2% |
| Q1 2018 | $1,380,000 | -14.0% | 300,000 | -40.0% | 1.05% | -16.9% |
| Q4 2017 | $1,605,000 | – | 500,000 | – | 1.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Biomark Capital Management Co. LLC | 1,433,304 | $6,464,000 | 99.88% |
| Broadfin Capital, LLC | 3,249,829 | $14,657,000 | 2.31% |
| Stonepine Capital Management, LLC | 831,731 | $3,751,000 | 2.28% |
| Aisling Capital LLC | 3,608,171 | $16,273,000 | 2.14% |
| Consonance Capital Management LP | 4,249,234 | $19,164,000 | 1.24% |
| MORGENS WATERFALL VINTIADIS & CO INC | 375,000 | $1,691,000 | 1.20% |
| Perceptive Advisors | 6,521,102 | $29,410,000 | 0.77% |
| PURA VIDA INVESTMENTS, LLC | 325,000 | $1,466,000 | 0.59% |
| 683 Capital Management, LLC | 885,000 | $3,991,000 | 0.27% |
| ARDSLEY ADVISORY PARTNERS LP | 80,000 | $361,000 | 0.05% |